Show Notes
Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also evolved significantly.
In this episode of The PJ Pod, Caitlin Killen, assistant clinical editor, speaks to a patient who has been living with CLL for 17 years, as well as with two pharmacists involved in the care of CLL patients, to understand how pharmacists can best support patients with CLL.
Many thanks to expert patient Anthea Holland; Catherine Parbutt, consultant pharmacist for cancer services, The Leeds Teaching Hospitals NHS Trust; and Tejal Gorasia, principal cancer pharmacist, Milton Keynes University Hospital NHS Foundation Trust, for their expertise.
This episode was produced by Geoff Marsh.
More from The PJ Pod
For Tase Oputu, becoming the first president of the Royal College of Pharmacy is “the greatest honour of my career”, and she says the move to a royal college is already changing how pharmacy is received by policymakers.
In this episode of Pharmacy Inside Jobs, senior editor, research and learning Alex Clabburn talks to Ed Hindle.
Electronic Prescription System (EPS) nominations connect patients with the pharmacy where they can collect their medication – and often access other services, help and advice while they’re there.
In this episode of Pharmacy Inside Jobs, Joanna Robertson, senior clinical reporter, talks to Mark Stuart, a sports pharmacist whose 25-year career has spanned Olympic, Paralympic and Commonwealth games, as well as anti-doping education at the International Testing Agency.
In this episode of The PJ Pod, senior features editor Siobhan Chan examines how the issue of antimicrobial resistance (AMR) is being communicated outside of traditional clinical and policy settings.